| Literature DB >> 24372352 |
Ania Korszun1, Shah-Jalal Sarker, Kashfia Chowdhury, Charlotte Clark, Paul Greaves, Rachel Johnson, Judith Kingston, Gill Levitt, Janet Matthews, Peter White, Andrew Lister, John Gribben.
Abstract
To assess the impact of cancer (IOC) on subsequent quality of life (QOL), 718 long-term haematological cancer survivors completed validated psychosocial, functional and QOL scales, including IOC. Fifteen percent reported significant psychological distress, 18% high levels of fatigue and 10% moderate to severe functional impairment. These groups of participants also showed poorer QOL. There were no significant differences in psychological distress (P = 0·76), fatigue (P = 0·23) or functional impairment (P = 0·74) across different cancer subtypes. Two separate hierarchical regression analyses examined the combined association of disease-type, psychosocial and other factors on negative and positive IOC scores respectively. Higher negative IOC scores were significantly associated (P ≤ 0·001) with medical comorbidity, psychological distress, lower social support, high fatigue levels and functional impairment. Paediatric patients (diagnosed at <17 years) had significantly higher negative IOC scores than adult patients (P = 0·001); greater years since diagnosis was significantly (P < 0·001) associated with less negative IOC. Higher positive IOC was associated with acute leukaemia (P = 0·01); lower positive IOC with paediatric patients (P < 0·001), white ethnicity (P < 0·001), higher education (P = 0·003), no partner (P = 0·01) and lower social support (P = 0·01). Screening for medical comorbidity, psychological distress and fatigue identifies those needing most support and should allow earlier interventions to address negative and positive IOC to improve the well-being of cancer survivors.Entities:
Keywords: depression; haematological cancer; long-term survivors; psychosocial factors; quality of life
Mesh:
Year: 2013 PMID: 24372352 DOI: 10.1111/bjh.12698
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998